Iridex Corp splits its revenue into 4 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jul 4, 2026 was Retina at $6.5 million, 52% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jul 4, 2026
|
Q2 FY2026
Jul 4, 2026
|
Q1 FY2026
Apr 4, 2026
|
Q3 FY2025
Sep 27, 2025
|
Q2 FY2025
Jun 28, 2025
|
Q1 FY2025
Mar 29, 2025
|
Q4 FY2024
Dec 28, 2024
|
Q3 FY2024
Sep 28, 2024
|
Q2 FY2024
Jun 29, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
|
13
|
12
|
12
|
14
|
12
|
13
|
12
|
13
|
| Retina |
—
|
6
-19.4%
share 51.6%
|
6
-12.3%
share 49.4%
|
7
+3.8%
share 53.7%
|
8
+10.3%
share 59.3%
|
7
share 55.9%
|
7
share 57.6%
|
6
share 55.7%
|
7
share 57.8%
|
| Cyclo G Six |
—
|
4
+19.0%
share 31.2%
|
4
+14.5%
share 30.9%
|
4
+13.1%
share 28.3%
|
3
-1.3%
share 24.3%
|
3
share 26.7%
|
3
share 25.8%
|
3
share 27.0%
|
3
share 26.4%
|
| Product And Service Other |
—
|
2
-3.1%
share 17.2%
|
2
+12.5%
share 19.7%
|
2
+12.2%
share 18.0%
|
2
+11.5%
share 16.4%
|
2
share 17.4%
|
2
share 16.6%
|
2
share 17.3%
|
2
share 15.8%
|
| Services |
—
|
0
-53.4%
share 2.4%
|
0
+4.5%
share 3.0%
|
0
-60.0%
share 3.2%
|
1
+9.0%
share 4.8%
|
0
share 2.8%
|
1
share 7.9%
|
1
share 8.6%
|
1
share 4.8%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- IRIX (Nasdaq)
- Fiscal year ends
- January 3
- Incorporated in
- DE
- Headquarters
- Mountain View, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1006045
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.